Category: Joint ventures/collaborations
-
Governments, Private Investors Unveil Clean Energy Plans
30 November 2015. Two separate but related initiatives from governments and private investors were unveiled today to boost investment in clean energy innovations for reducing the threat of climate change. Statements announcing the initiatives, expected to double global government spending on clean energy innovation to $20 billion, were made to coincide with the opening of…
-
Genomic, Patient Data Integrated for Precision Medicine
18 November 2015. A collaboration of genomic profiling and software companies plans to integrate their services to provide what they call more informed precision medicine treatment options for cancer patients. Financial aspects of the agreement between genetic diagnostics enterprise Caris Life Sciences in Irving, Texas and software provider Syapse in Palo Alto, California were not…
-
Brain Tissue Banks Partner on Autism Research
18 November 2015. Two repositories of brain tissue for research on neurological disorders agreed to coordinate their donation and distribution policies for studies of autism. The agreement aims to bring into alignment policies and practices of NeuroBioBank at National Institutes of Health and Autism BrainNet, a private tissue bank. The deal covers brain tissue samples…
-
Licensing, Research Deal Aims at Chronic Wound Treatments
16 November 2015. Umeå University and the pharmaceutical company Prometic are partnering on development of new treatments for chronic wounds, such as diabetic foot ulcers and bed sores. The agreement gives Prometic, in Laval, Quebec, Canada an exclusive license to the university’s research on the blood plasma protein plasminogen, with the company funding further studies…
-
Penn, Epic Sciences Partner on Liquid Biopsies
13 November 2015. University of Pennsylvania’s medical school plans to apply liquid biopsy technology developed by Epic Sciences to gain a more detailed understanding of different cancers for individual patient therapies. Financial terms of the agreement between the university and the San Diego biotechnology company were not disclosed. Epic Sciences’s technology detects and analyzes circulating…
-
Alliance Plans Adaptive Clinical Trials for Brain Cancer
12 November 2015. A global collaboration plans a series of clinical trials that address precise molecular targets testing treatments for glioblastoma multiforme, an aggressive brain cancer. The alliance combines medical teams, researchers, and patient advocates to employ adaptive clinical trials, a type of clinical study that enables investigators to adjust research tactics as results with…
-
USC, Biotech Edit Genes in Stem Cells for HIV Therapy
10 November 2015. A lab at University of Southern California and biotechnology company developed a technique for editing genomes in blood-forming stem cells as a potential treatment for HIV infection. The team from the lab of USC medical school professor Paula Cannon and Sangamo BioSciences in Richmond, California published its findings yesterday in the journal…
-
Winners of ALS Variation Models Challenge Announced
5 November 2015. Participants from universities in the U.S. and Taiwan are winners of a challenge to develop mathematical models that predict variations in progression of ALS in patients with the disease. The Dream ALS Stratification Prize4Life Challenge is a joint undertaking of Sage Bionetworks, a not-for-profit biomedical research organization, Dialogue on Reverse Engineering Assessment…
-
Biotech, Accelerator to Partner on Glaucoma Treatment
30 October 2015. A new eye-drop treatment for the underlying causes of glaucoma is being developed in a collaboration between a biotechnology enterprise spun-off from Northwestern University and a company that acquires biomedical research assets. Financial aspects of the deal between Mannin Research Inc. in Toronto, Ontario, Canada and Q BioMed Inc. in New York…
-
Univ Lab, Spin-Off Developing Drug from Turmeric
28 October 2015. A university biochemistry lab and spin-off enterprise developing drugs from plants are collaborating on a process for extracting a key ingredient for an anti-inflammatory compound from the common spice turmeric. The project, bringing together the lab of biochemistry professor David Gang at Washington State University and Botanisol LLC in Scottsdale, Arizona, is…